Deepa Varma

News

Few Cancer Survivors Meet ACS Nutrition, Exercise Guidelines

Author:: Deepa Varma

Publish date: April 26, 2024

Researchers estimate more than 9,000 survivors’ adherence to weight, physical activity, fruit and vegetable consumption, and alcohol intake guideli...

News

Time to Lung Disease in Patients With Dermatomyositis Subtype Estimated

Author:: Deepa Varma

Publish date: April 22, 2024

“Establishing an accurate timeline between MDA5 antibody-positive DM and ILD can promote urgency among dermatologists to evaluate extracutaneous ma...

News

FDA Approves AI Diagnostic Tool for Early Sepsis Detection

Author:: Deepa Varma

Publish date: April 18, 2024

Using both biomarkers and clinical data with the assistance of AI, the Sepsis ImmunoScore helps assess the risk for the presence of or progression ...

News

Certain Women May Face Higher Risk for Second Breast Cancer

Author:: Deepa Varma

Publish date: April 17, 2024

Two and a half percent of breast cancer survivors developed a second primary breast cancer, a new study shows.

News

Is Axillary Surgery in Early Breast Cancer on Its Way Out?

Author:: Deepa Varma

Publish date: April 16, 2024

Trial randomizes more than 2,000 patients to receive either axillary lymph node dissection or sentinel-node biopsy only.

News

Acne Risk With Progestin-Only Long-Acting Reversible Contraceptives Evaluated

Author:: Deepa Varma

Publish date: March 21, 2024

The authors concluded that “concerns about the development or worsening of acne should not be cause to avoid these forms of contraception.”

News

Secondary Cancers Post CAR T Therapy: A Concern?

Author:: Deepa Varma

Publish date: March 20, 2024

FDA analysis of adverse events following CAR T-cell therapy reports on the incidence of secondary blood cancers.

News

Treating Pediatric Vitiligo: Consensus Statement Provides Recommendations

Author:: Deepa Varma

Publish date: March 14, 2024

While half of all vitiligo cases manifest within the initial two decades of life, no guidelines specifically address the management of vitiligo in ...

News

Can Changes to Chemo Regimens Improve Drug Tolerability in Older Patients?

Author:: Deepa Varma

Publish date: March 5, 2024

Researchers evaluated the association between primary treatment modifications to chemotherapy regimens and treatment tolerability.

News

Is MRI Screening Unnecessarily High in Prostate Cancer?

Author:: Deepa Varma

Publish date: February 21, 2024

Expert emphasizes the necessity of observing a decrease in overall prostate cancer incidence before asserting that the current cancer diagnostics e...

News

Should CRC Surveillance Extend Beyond 5 Years Post Surgery?

Author:: Deepa Varma

Publish date: February 16, 2024

“Symptoms or suspicion of a cancer occurring 5-10 years from primary CRC treatment is more likely to represent a non-CRC cancer.”

News

Cancer Surgery Tied to Increased Venous Thromboembolism Risk

Author:: Deepa Varma

Publish date: February 14, 2024

The temporal trends showed that the risk for pulmonary embolism and deep vein thrombosis peaked immediately after surgery and plateaued within 120 ...

News

Do Multivitamin Supplements Lower Mortality Risk in CRC?

Author:: Deepa Varma

Publish date: February 13, 2024

Researchers assess whether multivitamin use affects overall survival among people with CRC.

News

Belantamab Mafodotin Tops Daratumumab in Multiple Myeloma

Author:: Deepa Varma

Publish date: February 13, 2024

The anti-BCMA monoclonal antibody conjugate outperformed daratumumab as a second-line option for relapsed or refractory multiple myeloma.

News

Chemo-Free Maintenance Strategies May Boost Survival in TNBC

Author:: Deepa Varma

Publish date: January 30, 2024

Researchers evaluated 45 patients with TNBC who had ongoing stable disease or complete/partial response from first- or second-line platinum-based c...